Calidi Biotherapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
10.00
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
2
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
0.00
|
-0.06
|
0.00
|
0.00%
|
|
2024-06-30
|
-1.43
|
-1.40
|
0.03
|
2.10%
|
|
2024-03-31
|
-0.28
|
-0.20
|
0.08
|
28.57%
|
|
2023-12-31
|
-0.20
|
-0.48
|
-0.28
|
-140.00%
|
|
2023-09-30
|
-0.17
|
-0.14
|
0.03
|
17.65%
|
|
2023-06-30
|
0.00
|
-0.43
|
0.00
|
0.00%
|
|
2023-03-31
|
0.00
|
-2.25
|
0.00
|
0.00%
|
|
2022-12-31
|
0.00
|
-0.26
|
-0.26
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-1.66
|
|
2023-12-31
|
-3.30
|
|
2022-12-31
|
-0.05
|
|
2021-12-31
|
0.12
|